ESPOGEN 4000 IU INJECTION
| Product Name | Espogen 4000 IU Injection |
| Active Ingredient | Erythropoietin Alfa |
| Strength | 4000 IU |
| Dosage Form | Injection |
| Therapeutic Class | Erythropoiesis-Stimulating Agent |
| Indication | Anemia (CKD / Chemotherapy) |
| Administration Route | Subcutaneous / Intravenous |
| Storage | Refrigerate at 2°C–8°C, protect from light |
| Prescription | Required |
ESPOGEN 4000 IU INJECTION
Espogen 4000 IU Injection is a recombinant erythropoietin therapy used to treat anemia associated with chronic kidney disease, dialysis, and certain chemotherapy treatments. It contains erythropoietin alfa, a synthetic form of the natural hormone that stimulates red blood cell production in the bone marrow. This helps restore hemoglobin levels and improve oxygen delivery throughout the body.
Espogen 4000 Injection is commonly recommended for patients experiencing fatigue, weakness, and shortness of breath due to low red blood cell counts. Gradually increasing RBC production supports improved stamina and reduces the need for frequent blood transfusions. Regular monitoring of hemoglobin levels ensures safe and effective dosage management.
Espogen 4000 Injection offers reliable therapeutic performance and safety. It is widely supplied to hospitals, nephrology clinics, and global pharmaceutical markets for dependable anemia management solutions.
Product Features
- Contains Erythropoietin Alfa 4000 IU
- Stimulates natural red blood cell formation
- Used in CKD and chemotherapy-related anemia
- Helps minimize blood transfusion requirements
- High-quality sterile injectable formulation
How It Helps
- Improves hemoglobin levels
- Enhances oxygen supply to tissues
- Reduces fatigue and weakness
- Supports consistent anemia control

Reviews
There are no reviews yet.